A Study of sEphB4-HSA in Kaposi Sarcoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 17, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

June 30, 2025

Conditions
Kaposi Sarcoma
Interventions
DRUG

sEphB4-HSA

sEphB-HSA may prevent tumor cells from multiplying and blocks several compounds that promote the growth of blood vessels that bring nutrients to the tumor.

Trial Locations (3)

34237

RECRUITING

CAN (Community AIDS Network) Community Health, Sarasota

75390

RECRUITING

UT Southwestern Medical Center, Dallas

90211

RECRUITING

AIDS Healthcare Foundation, Beverly Hills

All Listed Sponsors
lead

Vasgene Therapeutics, Inc

INDUSTRY